Boehringer Ingelheim launches Metacam Injection for cats
Boehringer Ingelheim has launched a cat-specific presentation of Metacam Injection combined with a new indication which permits the company's existing oral suspension (0.5mg/ml meloxicam) to be used for up to four follow-on days. The company says this will give veterinary surgeons increased flexibility for managing feline post-operative pain, and that the new Metacam 2mg/ml Injection helps accurate dosing. Used at the recommended dose rate of 0.2mg/kg, the injection can be followed by Metacam 0.5mg/ml Oral Suspension to provide up to five days of analgesia following surgical procedures in cats...